Melanin-aware AI platform for objective dermatology & clinical trials
MyMonitor.ai is an AI-driven healthcare platform that transforms standard skin images into high-fidelity, objective medical data. By addressing the critical "melanin gap" in computer vision, our technology reduces subjectivity in dermatologic assessments and clinical trial screening. Our mission is to provide standardized, data-driven clinical decision support that ensures equitable skin health outcomes across all populations.
Methodology & Technology: Our platform utilizes a proprietary deep learning architecture optimized for the analysis of diverse skin tones. The methodology involves automated lesion quantification, boundary detection, and longitudinal severity tracking. Unlike traditional "black box" AI, our system provides structured data outputs designed for seamless API integration into existing EHR systems and Decentralized Clinical Trial (DCT) platforms.
Proof to Date & Metrics: The platform has been validated through active pilot deployments and strategic institutional collaborations with Temple University and Worcester Polytechnic Institute (WPI).
Key metrics from current validation include: Efficiency: Automated analysis and structured reporting in <3.8 seconds per image. Reliability: Inter-rater agreement scores of κ > 0.9, significantly reducing site-to-site variability.
Traction: Active pilot activity with Clinical Research of Philadelphia and Dermatology Partners focusing on remote lesion severity tracking.
Next Steps & Validation Plans: We are currently seeking co-development partners, CROs, and pharmaceutical organizations to initiate larger-scale validation studies within Phase II/III clinical trials.
Our immediate validation goals include: Head-to-head validation of automated scoring against gold-standard manual assessments (e.g., PASI/EASI) in melanin-rich populations.
Expansion of our longitudinal dataset to include rare inflammatory conditions. Pilot engagements with teledermatology to evaluate clinical throughput improvements.
About MyMonitor Corporation
MyMonitor Corporation is a healthcare technology company that has developed an AI-driven platform designed to modernize dermatological assessment and clinical research. The system functions by converting standard skin images into structured, objective clinical data, aiming to reduce diagnostic variability and improve the precision of skin condition management. A core feature of the platform is its use of melanin-aware imaging technology, which is intended to support more equitable and inclusive diagnostics across diverse skin tones. Beyond image analysis, the platform provides tools that integrate with healthcare systems and electronic health records to streamline workflows for clinicians and stakeholders in the dermatological field.
This technology is intended to assist a wide range of organizations, including hospitals, clinics, and health systems, by enhancing diagnostic accuracy and facilitating more efficient patient care. Additionally, the platform addresses needs within clinical trials by offering smart recruitment strategies and ensuring diverse patient enrollment. By shifting dermatology toward a more data-driven approach, MyMonitor seeks to transform subjective visual assessments into measurable medical insights, ultimately aiming to improve patient outcomes and support research evidence generation from bedside to benchside. The company, which is based in the United States, focuses on closing the gap between traditional dermatological practice and modern data science.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.